SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as the community eagerly anticipates topline Phase 3 SOL-1 data for its wet AMD treatment, AXPAXLI, set to be presented at a major scientific meeting, fueling discussions around potential positive results, a high-profile new CCO hire, and renewed acquisition interest following a prior rejected offer.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending due to contrasting views on its Gemini-II AI chip's capabilities, with bulls highlighting recent preliminary benchmarks for low-power edge multimodal LLM inference and a government-backed defense project, while bears aggressively question the reported 3-second processing time and prior disclosures, prompting a law firm's securities investigation.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is surging after reporting a Q4 earnings beat and robust 2026 delivery guidance, coupled with excitement over its upcoming R2 SUV launch, prompting significant analyst upgrades and fueling community discussions about a potential short squeeze.

At Bluzelle, we see technology as a powerful tool to solve humanity's most pressing challenges. As creators of a robust decentralized blockchain ecosystem—including the Bluzelle Chain, BLZ token, and NFT marketplace Capella—we are uniquely positioned to revolutionize how science is conducted, funded, and shared. Our DeSci (Decentralized Science) platform is designed to empower all scientific fields, fostering innovation across disciplines.

Bluzelle

Bluzelle (BLZ) is trending amidst high volatility as the crypto community debates whether recent pumps signal a rebound from its Binance delisting or if it is experiencing a pump-and-dump, with bulls highlighting its low circulating supply and new AI developments while skeptics point to sustained selling pressure and low volume.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as its community anticipates a significant market shift from impending quantitative easing, fueling strong speculation for a "short squeeze" and a major rally, underpinned by bullish technical indicators and a widespread belief that the asset is heavily "undervalued" despite some recent adoption challenges.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals is trending following key FDA approvals for Eylea HD and an expanded label for Libtayo, bolstering its oncology and ophthalmology pipelines, though community discussion balances this with concerns over competition for its foundational Eylea product.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint &amp; redeem rTokens.

StaFi

StaFi (FIS) is trending due to its recently announced token burn proposal aiming for deflationary tokenomics and a new roadmap, generating significant bullish sentiment within the community. Despite a recent delisting, many are anticipating substantial upside as a liquid staking protocol, citing its perceived low market cap and continued presence on major exchanges.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is surging following robust earnings that exceeded expectations and provided strong guidance, primarily driven by the escalating demand for AI chips and a recovering memory sector. The company's critical role in semiconductor equipment manufacturing is drawing significant community attention and analyst upgrades, fueling a bullish outlook across the sector.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending following its announced $7.5 billion all-cash acquisition of Silicon Labs, with its stock pulling back as the community weighs the high price and long 2027 closing timeline against the strategic expansion into wireless connectivity and embedded solutions.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is buzzing following its selection for NVIDIA's DRIVE Hyperion platform and the launch of new 4D LiDAR sensors for physical AI, sparking robust community debate over its significant validation against concerns about current valuation, dilution risks, and long-term revenue timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Diego Pellicer Worldwide, Inc. leases real estate to licensed cannabis operators. It is also involved in the management of operations and other third-party cannabis operators deriving income from management and royalty fees. The company was founded by Jamen Shivley and Douglas Anderson in 2012 and is headquartered in Reno, NV.

Diego Pellicer Worldwide Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

DPWW
Diego Pellicer Worldwide Inc

Feed

News

Sentiment

Fundamentals

Info

Latest DPWW News

DPWWDiego Pellicer Worldwide Inc